Catalogo dei prodotti della ricerca

D'ASCENZIO, MELISSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 752
EU - Europa 198
AS - Asia 91
AF - Africa 6
SA - Sud America 3
Totale 1.050
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 749
IT - Italia 89
IN - India 37
DE - Germania 30
SG - Singapore 26
CN - Cina 23
SE - Svezia 21
GB - Regno Unito 20
FI - Finlandia 18
UA - Ucraina 7
TG - Togo 4
AR - Argentina 3
CA - Canada 3
TR - Turchia 3
ES - Italia 2
FR - Francia 2
IE - Irlanda 2
MA - Marocco 2
MY - Malesia 2
RO - Romania 2
AL - Albania 1
BG - Bulgaria 1
EE - Estonia 1
LV - Lettonia 1
NO - Norvegia 1
Totale 1.050
Salva come PNG Salva come JPEG
Città #
Fairfield 144
Woodbridge 80
Ashburn 72
Seattle 60
Cambridge 51
Wilmington 50
Houston 46
Rome 32
Chandler 21
Ann Arbor 17
Dearborn 17
Princeton 17
New York 16
Singapore 16
Plano 15
San Paolo di Civitate 14
Latina Scalo 12
Lawrence 12
Beijing 11
San Diego 11
Grafing 9
Millbury 9
Boston 7
Cagliari 6
Helsinki 5
Norwalk 5
Lomé 4
Andover 3
Bremen 3
Federal 3
Hefei 3
Jacksonville 3
Bursa 2
Chieti 2
Delhi 2
Des Moines 2
Dimāpur 2
Dublin 2
Falls Church 2
Fasano 2
Fonte Nuova 2
Laurel 2
Meknes 2
Redwood City 2
Salamanca 2
Simi Valley 2
Aizawl 1
Berlin 1
Bolzano Vicentino 1
Campobello Di Mazara 1
Changchun 1
Falkenstein 1
Fulham 1
Guangzhou 1
Huzhou 1
Indiana 1
Istanbul 1
Janesville 1
Kuching 1
Kunming 1
Las Vegas 1
Los Angeles 1
Mannheim 1
Massimeno 1
Montréal 1
Munich 1
Oslo 1
Ottawa 1
Pontinia 1
Provo 1
Riga 1
Shanghai 1
Shenyang 1
Sofia 1
Southend 1
Tallinn 1
Taramani 1
Tirana 1
Toronto 1
Washington 1
Wuhan 1
Totale 837
Salva come PNG Salva come JPEG
Nome #
Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity 108
Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma 94
Recent advances in the development of selective human MAO-B inhibitors: (Hetero)arylidene-(4-substituted-thiazol-2- yl)hydrazines 92
4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis 83
Synthesis and selective inhibition of human monoamine oxidases of a large scaffold of (4,5-substituted-thiazol-2-yl)hydrazones 82
Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii 81
Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors 74
Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives 72
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII—A new scaffold for designing isoform-selective inhibitors 69
Synthesis, anti-Candida activity, and cytotoxicity of new (4-(4-iodophenyl)thiazol-2-yl)hydrazine derivatives 61
Selective MAO-B inhibitors: a lesson from natural products 58
Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential 57
null 54
null 50
Synthesis and biological evaluation of new potential co-adjuvants for the treatment of Parkinson’s disease and a new catalytic, asymmetric approach to the synthesis of fused heterocycles of biological interest. 38
New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: Biological evaluation and molecular modelling studies 14
Opening new scenarios for human MAO inhibitors 13
Totale 1.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.682
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020270 0 0 0 15 27 39 49 40 47 28 15 10
2020/2021101 8 11 9 3 0 10 0 9 26 18 6 1
2021/2022173 1 13 20 2 19 5 9 14 11 11 38 30
2022/2023136 33 32 1 11 11 12 2 8 15 1 10 0
2023/2024104 5 13 5 6 8 35 0 15 1 6 1 9
2024/202531 1 11 16 3 0 0 0 0 0 0 0 0
Totale 1.100